Last reviewed · How we verify
NCT05346211
The Effect of Curcumin Supplementation on Recovery From Exercise-induced Muscle Damage
NA trial testing Curcumin in Exercise Induced Muscle Damage in 36 participants. Status unknown.
30 September 2022
Quick facts
| Lead sponsor | St Mary's University College |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 36 |
| Start date | 1 May 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2023 |
Drugs / interventions tested
- Curcumin (CURCUMIN) — full drug profile →
Conditions studied
- Exercise Induced Muscle Damage — all drugs for Exercise Induced Muscle Damage →
Sponsor
St Mary's University College
Who can join
Adults 18 to 35, any sex, with Exercise Induced Muscle Damage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recent evidence suggests that curcumin supplementation may reduce muscle inflammation, oxidative markers, and muscle damage. The most favourable dosage to elicit these ergogenic effects are yet to be established; both 750mg \& 1500mg has been shown to be effective. Curcumin supplementation has been ingested in numerous different ways however, no previous research to date has used curcumin in a hydrolysed (drinkable) format. The aim of this study is to investigate whether hydrolysed curcumin can reduce indices of muscle damage and improve recovery, whilst also examining a potential dose-response effect.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05346211
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Curcumin
Trials testing the same drug.
- NCT07436130 — Curcumin in Critically Ill Patients With Sepsis · NA · not yet recruiting
- NCT07251985 — Cognitive Effects of Bioavailable Curcumin · Phase 2 · not yet recruiting
- NCT07379177 — Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human · NA · not yet recruiting
- NCT07523256 — Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia · NA · completed
- NCT06531863 — Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance · EARLY_PHASE1 · recruiting
Other recruiting trials for Exercise Induced Muscle Damage
Currently open trials in the same condition.
- NCT07219498 — Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness · NA · recruiting
- NCT07503860 — Indirect Biomarkers and Exercise Induced Muscle Damage · NA · active not recruiting
- NCT06810271 — Walk It Off! the Influence of Physical Activity Level on the Recovery from Damaging Resistance Exercise · NA · active not recruiting
Other St Mary's University College trials
Trials by the same sponsor.
- NCT05571475 — The Effects of Simulated Competition on Repeated-sprint Cycling Performance · NA · unknown
- NCT05521386 — The Effects of Caffeine on Heart Rate and Heart Rate Variability · NA · unknown
- NCT05313932 — The Effects of Sleep Deprivation on Physiological and Perceptual Responses During Exercise · NA · unknown
- NCT05302739 — The Effects of Facial Cooling on Fencing Performance · NA · unknown
- NCT05268354 — Modification of Risk Factors Associated With Knee Injury in Netball · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05346211 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St Mary's University College
- Last refreshed: 26 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05346211.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing